Huadao Biopharma

Shanghai, China · Founded 2017 · Privately Held (backing)

Developer of cell immunotherapy technology designed for oncology. Huadao Biopharma is based in Shanghai, China and was founded in 2017. Its last reported valuation was $79.9 million in Jul 2019. It has raised $58.8 million.

Last reported valuation
$79.9M
Oct 2026
Priced at
—
Total raised
$58.8M
Last round
—

Who backs Huadao Biopharma?

20 investors
InvestorType
Hankang CapitalVenture capital
Shanghai Songjiang State-owned Assets InvestmentOther
Jiaxing Jiarui Investment ManagementOther
Zhejiang Haiyue Asset ManagementOther
Chongqing Technology Venture CapitalOther
Huzhou Innovation Venture CapitalOther
Chongqing Kexing Kechuang Investment—
Donghao Lansheng Investment—
HY Energy Group—
Jiaxing Shiye Asset Investment Group Co.—
+ 10 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Huadao Biopharma investors

Free account
More of Huadao Biopharma with a free account
  • ·The complete investor list: 20 names
  • ·Watch Huadao Biopharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 20 firms already write checks for companies like Huadao Biopharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View